Drugs & Medical Devices
Get ready for the next wave of pharmaceutical litigation with HarrisMartin's Drugs & Medical Devices. This reporter will keep you one step ahead of drug and medical device litigation with in-depth investigations, guest commentaries and objective courtroom coverage on today's and tomorrow's hottest drugs and supplements.
SEARCH THE ARCHIVES
Issue #7, July 2002
The new FDA-approved warning labels accompanying the arthritis drug Celebrex will continue to educate patients and physicians of the potential risk of gastrointestinal events associated with the anti-inflammatory drug, and include new information for elde
A federal judge issued a scathing memorandum directed at attorneys for GlaxoSmithKline, noting discrepancies of its responsive pleading to a products liability action involving the drug Baycol.
A federal judge has granted a motion to remand a Lotronex product liability suit after finding that the defendants failed to conclusively prove the existence of federal jurisdiction and fraudulent joinder among non-diverse defendants in a lawsuit against
Plaintiffs in a federal class action lawsuit filed against the manufacturers of the anti-depressant Serzone have submitted a petition before the Judicial Panel on Multidistrict Litigation asking it to consolidate and transfer similar cases to the U.S. Dis
Issue #6, June 2002
An extensive interview with Rezulin expert and drug litigation consultant Dr. Brent Neuschwander-Tetri of the Saint Louis University Health Sciences Center.